Supine Versus Left Lateral Tilted Position During Cesarean Delivery
NCT ID: NCT03182114
Last Updated: 2018-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
450 participants
INTERVENTIONAL
2017-06-12
2019-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemodynamic Effect of Left Tilting in Cesarean Delivery
NCT03181776
An Evaluation of Maternal Position During Cesarean Delivery
NCT02872181
Comparison of Vasopressor Boluses for Management of Hypotension After Spinal Anesthesia
NCT03712111
Prevention of Post-spinal Anesthesia Hypotension in Caesarean Delivery Using Delayed Supine Positioning
NCT04777123
Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section
NCT05671172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
supine position
the patient will receive spinal anesthesia by Bupivacaine; then she will be placed in supine position
supine position
the patient will be placed in regular supine position after spinal anesthesia
Bupivacaine
The patient will receive 10 mg Bupivacaine for spinal anesthesia
Left lateral tilted position
the patient will receive spinal anesthesia by Bupivacaine; then she will be placed in left lateral tilted position
left lateral tilted position
the patient will be placed in left lateral tilted position after spinal anesthesia
Bupivacaine
The patient will receive 10 mg Bupivacaine for spinal anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
supine position
the patient will be placed in regular supine position after spinal anesthesia
left lateral tilted position
the patient will be placed in left lateral tilted position after spinal anesthesia
Bupivacaine
The patient will receive 10 mg Bupivacaine for spinal anesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnant women
* scheduled for elective cesarean delivery
Exclusion Criteria
* hypertensive disorders of pregnancy
* peripartum bleeding
* baseline systolic blood pressure (SBP) \< 100 mmHg
* body mass index \> 35
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Hasanin
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Mukhtar, Professor
Role: STUDY_CHAIR
Head of research committee section in anesthesia department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-52-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.